The intrinsic components of the nanoparticles (NPs), which are surface- bound to the polymeric matrix, may include the active agents, which will have sizes ranging from 1 to 1000 nm. These can be used as drug carriers to increase the therapeutic window and bioavailability, provide regu­lated release, and shield different desired chemicals from the environment (Zielinska etal., 2020). Depending on the process used to make nanocapsules or nanospheres, one could coat nanopar­ticles. The medicine in nanocapsules is contained within a cell surrounded by a polymer mem­brane, whereas the drug in nanospheres is encased in a matrix that has particles physically scattered throughout it (Soppimath etal., 2001). Because of their exceptional stability and their capacity to transport both hydrophilic and hydrophobic molecules, nanoparticles are a promising option for the delivery of pharmaceuticals. It is also possible to administer them either orally or by means of inhalation. According to Gelperina (2005), these carriers might be made to enable the medication’s gradual, controlled release. Furthermore, Mughees et al.’s 2021 research emphasizes the useful­ness of nanoparticles in conjunction with phytochemicals and herbal extracts as a targeted antican­cer therapeutic approach, albeit one with some drawbacks. Nanoparticles can be used as effective medicine carriers because they are highly stable, have a high carrier capacity, and can contain both hydrophobic and hydrophilic compounds. In addition, they can be given orally using a number of methods, including inhalation. According to Gelperina (2005), these carriers might also be made to make it easier for the drugs to release matrix- regulated over a longer time frame. Mughees etal. (2021) state that polymeric nanoparticles work against cancer by delivering medications in a safe and effective manner when paired with phytochemicals and herbal extracts. Similarly, liposomes containing lipid nanoparticles are among the few lipidic nanoparticles. Liposomes are tiny lipid­containing vesicles with a diameter of 0.1–10 nm that have a watery core surrounded by two layers of phospholipid. Agrahari etal. (2016) state that there are three different types of liposomes based on size and lipid bilayers: tiny unilamellar vesicles, big uniagellar vesicles, and multilamellar vesicles. According to Eloy etal. (2017), it can be utilized to combine hydrophilic and lipophilic compounds. It is anticipated that using liposomes to target certain pharmaceuticals may improve the medications’ therapeutic effects, reduce any potential toxicity, and eliminate localized irritation.